drugset / Trial / NCT02922699

Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases

NCT02922699

Phase 4 Completed 120 enrolled Dr. Reddy's Laboratories Limited
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparison of efficacy of H.pylori eradication during first line therapy using standard or high doses of omeprazole administered twice daily in combination with amoxicillin and clarithromycin for 10 days.

Timeline

Start
2013-01
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 40 mg
Subject Omeprazole Other / unclassified 80 mg